- Original article
- Open access
- Published:
Incidence of ventilator-associated pneumonia: Egyptian study
Egyptian Journal of Bronchology volume 13, pages 258–266 (2019)
Abstract
Background
Despite different ICU admission causes, ventilator-associated pneumonia (VAP) is still a common cause of mortality and morbidity in intubated patients and impedes obvious progression in diagnostic modalities and management of these infections.
Aim of study
The aim of this study was to estimate VAP incidence in Tanta University Hospitals ICUs.
Settings and design
This was a crossover observational study.
Patients and methods
This was a one-year study (April 2015 to March 2016), including patients on invasive ventilation who developed VAP, with evaluation of admission and ventilation causes, isolation of causative organisms, and study of used antibiotics and ventilation modes.
Statistical analysis
Data were statistically analyzed using the SPSS software for Windows (IBM SPSS Statistics 21.0).
Results
It is a statistics based study aimed to trace infection incidence in national hospital ICUs. Among 222 admitted patients, only 38.4% fulfilled the criteria of VAP. Admission was because of cardiovascular impairment, cardiac arrest, respiratory failure, or head trauma. The ventilation mode at VAP time was assisted control (75%) and synchronized intermittent mandatory ventilation (25%). The minimum intubation period was 7 days, whereas the maximum period was 37 days. Isolated organisms were Pseudomonas (37.5%), Klebsiella (25%), Staphylococcus (20.8%), and methicillin-resistant Staphylococcus aureus (4.2%). The antibiotics used were amikacin, imipenem, vancomycin, levofloxacin, ceftazidime, and teicoplanin (29, 25, 21, 12.5, 8.3, and 4.2%, respectively). The minimum period of antibiotic used was 5 days, whereas the maximum period was 35 days. The highest incidence of VAP occurred in February, whereas the lowest incidence occurred in July.
Conclusion
The incidence of VAP is still high and varies according to the intubation cause and period, and the underlying morbidity. More efforts must be made to prevent, diagnose, and manage infection early and properly to reduce patient suffering and to reduce the burden on the serving hospitals.
References
Lima J, Alves LR, Paz J, Rabelo MA, Maciel MAV, Morais MMC. Analysis of biofilm production by clinical isolates of Pseudomonas aeruginosa from patients with ventilator-associated pneumonia. Rev Bras Ter Intensiva 2017; 29:310–316.
Fialkow L, Farenzena M, Wawrzeniak IC, Brauner JS, Vieira SR, Vigo A, et al. Mechanical ventilation in patients in the intensive care unit of a general university hospital in southern Brazil:an epidemiological study. Clinics 2016; 71:144–151.
Slutsky AS. History of mechanical ventilation. from vesalius to ventilator-induced lung injury. Am J Respir Crit Care Med 2015; 191:1106–1115.
Vincent JL, Akca S, De Mendonca A, Haji-Michael P, Sprung C, Moreno R, et al. The epidemiology of acute respiratory failure in critically ill patients(*). Chest 2002; 121:1602–1609.
American Thoracic S, Infectious Diseases Society of A. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388–416.
Torres A, Ferrer M, Badia JR. Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia. Clin Infect Dis 2010; 51 (Suppl 1):S48–S53.
Joseph NM, Sistla S, Dutta TK, Badhe AS, Parija SC. Ventilator-associated pneumonia in a tertiary care hospital in India:incidence and risk factors. J Infect Dev Ctries 2009; 3:771–777.
Khilnani GC, Jain N. Ventilator-associated pneumonia:changing microbiology and implications. Indian J Crit Care Med 2013; 17:331–332.
Ahmed NH, Hussain T, Biswal I. Antimicrobial resistance of bacterial isolates from respiratory secretions of ventilated patients in a multi-specialty hospital. Avicenna J Med 2015; 5:74–78.
Song X, Chen Y, Li X. Differences in incidence and outcome of ventilator-associated pneumonia in surgical and medical ICUs in a tertiary hospital in China. Clin Respir J 2014; 8:262–268.
Sharpe JP, Magnotti LJ, Weinberg JA, Brocker JA, Schroeppel TJ, Zarzaur BL, et al. Gender disparity in ventilator-associated pneumonia following trauma:identifying risk factors for mortality. J Trauma Acute Care Surg 2014; 77:161–165.
Goel V, Hogade SA, Karadesai S. Ventilator associated pneumonia in a medical intensive care unit:microbial aetiology, susceptibility patterns of isolated microorganisms and outcome. Indian J Anaesth 2012; 56:558–562.
Badr MA, Ali YF, Albanna EA, Beshir MR, Amr GE. Ventilator associated pneumonia in critically-ill neonates admitted to neonatal intensive care unit, Zagazig University Hospitals. Iran J Pediatr 2011; 21:418–424.
Gadani H, Vyas A, Kar AK. A study of ventilator-associated pneumonia:incidence, outcome, risk factors and measures to be taken for prevention. Indian J Anaesth 2010; 54:535–540.
Elgazzar AEMM. Clinical phenotype as a predictor of outcome in mechanically ventilated chronic obstructive pulmonary disease patients. Egypt J Bronchol 2018; 12:180–186.
Golia S, KT S, CL V. Microbial profile of early and late onset ventilator associated pneumonia in the intensive care unit of a tertiary care hospital in bangalore, India. J Clin Diagn Res 2013; 7:2462–2466.
Restrepo MI, Peterson J, Fernandez JF, Qin Z, Fisher AC, Nicholson SC. Comparison of the bacterial etiology of early-onset and late-onset ventilator-associated pneumonia in subjects enrolled in 2 large clinical studies. Respir Care 2013; 58:1220–1225.
Hashemi SH, Hashemi N, Esna-Ashari F, Taher A, Dehghan A. Clinical features and antimicrobial resistance of bacterial agents of ventilator-associated tracheobronchitis in Hamedan, Iran. Oman Med J 2017; 32:403–408.
Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis 2010; 51 (Suppl 1):S81–S87.
Chung DR, Song JH, Kim SH, Thamlikitkul V, Huang SG, Wang H, et al. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med 2011; 184:1409–1417.
Ahmad S, Bacha N, Bakht J, Ahmed J. Characterization of pathogens involved in ventilator associated pneumonia in surgical and medical intensive care units:a single center experience. Pak J Pharm Sci 2017; 30:2091–2099.
Rello J. Bench-to-bedside review:therapeutic options and issues in the management of ventilator-associated bacterial pneumonia. Crit Care 2005; 9:259–265.
Abd El-Kader AMM. Implications of some proinflammatory cytokines in ventilator associated pneumonia. Mansoura:Faculty of Medicine, Mansoura University; 2002.
Djordjevic ZM, Folic MM, Jankovic SM. Distribution and antibiotic susceptibility of pathogens isolated from adults with hospital-acquired and ventilator-associated pneumonia in intensive care unit. J Infect Public Health 2017; 10:740–744.
Ranjit S, Bhattarai B. Incidence and risk factor for ventilator-associated pneumonia in Kathmandu University Hospital. Kathmandu Univ Med J 2011; 9:28–31.
Ali HS, Khan FY, George S, Shaikh N, Al-Ajmi J. Epidemiology and outcome of ventilator-associated pneumonia in a heterogeneous ICU population in Qatar. Biomed Res Int 2016; 2016:8231787.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Elkolaly, R.M., Bahr, H.M., El-Shafey, B.I. et al. Incidence of ventilator-associated pneumonia: Egyptian study. Egypt J Bronchol 13, 258–266 (2019). https://doi.org/10.4103/ejb.ejb_43_18
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/ejb.ejb_43_18